Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.
about
Untangling tau imagingInsight into the Molecular Imaging of Alzheimer's DiseaseCharacteristics of Tau and Its Ligands in PET ImagingImaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence ImagingImaging pathological tau in atypical parkinsonian disordersClinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasA systematic review of lessons learned from PET molecular imaging research in atypical parkinsonismHigh affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selectionCurrent understanding of chronic traumatic encephalopathyCerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy.Imaging frontotemporal lobar degeneration.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Antibody-derived in vivo imaging of tau pathology.Tau PET imaging: present and future directions.Imaging biomarkers associated with cognitive decline: a review.In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging.In vivo quantification of cochlin in glaucomatous DBA/2J mice using optical coherence tomography.Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.PET Radioligands for Imaging of Tau Pathology: Current Status.Tau positron emission tomographic imaging in aging and early Alzheimer diseaseTau imaging in neurodegenerative diseases.PET imaging of neuropathology in tauopathies: progressive supranuclear palsyAssessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies.Harnessing the immune system for treatment and detection of tau pathology.In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals.Tau PET imaging in Alzheimer's disease.Developments in Tau PET Imaging.In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.Molecular and cellular pathophysiology of preclinical Alzheimer's disease.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Genetics of Frontotemporal Dementia.Biomarkers in Neurodegenerative Diseases.Imaging tau pathology in Parkinsonisms.Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly.Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.Biomathematical screening of amyloid radiotracers with clinical usefulness index.In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
P2860
Q26739091-A196C1C5-C1C4-402A-9266-3D701670DE77Q26765945-6C30C2D8-B709-4C2B-977F-F59570EC7243Q26769952-9D655AFC-F49A-4BB8-B913-4B250445FD56Q26770766-76866958-09DA-41A3-A407-AFA82277F6E3Q26823039-CD064AC6-E182-4AF9-94C6-F1F9C95B30D2Q27003078-8FEB9CE6-70AB-4032-A886-F78699BB608BQ28075227-EA5BD81E-BACC-4B1C-A03E-828E6BF2926BQ28241366-ADCBA78C-AF06-4C91-B4C4-8248892F3E33Q28383546-EEC1603B-A278-4624-81AC-41A1E354AD4FQ30275833-AB78FAAB-AF87-412B-94B6-5078FD09EF31Q30846573-DCD81CA4-A140-472D-8942-214BA8BD6AE4Q30996799-A2731042-4AF5-4445-A2DE-BE8488E74691Q34664345-275797DE-9466-4699-ACCE-BC417D122651Q34680852-03FCBDAF-87F1-4696-B727-AA6145739E56Q35185786-F085BC92-CD33-4F08-B356-E549C4400587Q35549386-F4C2ECDE-5BC5-4E4A-89B0-F666C62C3572Q35687425-6F9994B8-B92A-4BF0-9D1D-7A3AAEB213A8Q35804873-8DE70ADC-B54E-4F17-A9CA-BAC33337C511Q35810005-72DDCA8F-A846-4A84-890B-ABB2B7FA825EQ36241261-0F857C27-8ABA-4FBE-B070-C0BFB87523E9Q36535275-E35ED382-FAC6-42E2-B949-CFD7EB4AF5A6Q36834567-1E606536-EB93-4D2F-8474-F02DE76C5988Q36906654-3E064895-D716-4A6F-B5EB-12BFB0CC3840Q37691087-EC33210E-8FE3-4FCB-BF14-5F3CF4EF55C5Q38194049-EF25A9D5-FDC1-4D9C-BE89-0CDAED455438Q38195938-364B85C6-C873-469B-8966-194DB656B375Q38252750-B78F34CF-BB11-43BA-9B8F-FAAB149CFBE8Q38271405-F18CDED2-FAF3-4A63-83F2-FCC821A50977Q38436447-6D11BC45-A2CA-495B-A029-2111FDD40D58Q38810544-8FA682C2-1882-4A27-A258-C4CE660A06EBQ38836004-5F15AF9F-91F7-451E-A491-B1C71F78B2DAQ38979999-306F5372-444D-4A0B-8D36-975A8FAC38BCQ39017699-07D3C00C-56E0-4A5A-AAAE-D1FE9BD0361BQ39413097-AA2438D3-6846-46C8-BC2F-FEE8B96D544DQ39419877-5FCA6CA8-86DB-4794-AC82-694AAAF17B87Q39429271-F0D8B678-E004-4D60-83B0-334CAF94C650Q39544835-48260B14-2CFD-4F12-A3A1-876CF135DF70Q41535994-9A704D78-0BEE-4772-9E1C-7FADFBC51EF6Q47241835-CC5BA7A8-88D0-43CB-A233-CD999F2F05C9Q47865475-C7ECE3BC-C656-4098-A7C8-363F26A1BB13
P2860
Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Comparison of the binding char ...... Alzheimer's disease pathology.
@en
Comparison of the binding char ...... Alzheimer's disease pathology.
@nl
type
label
Comparison of the binding char ...... Alzheimer's disease pathology.
@en
Comparison of the binding char ...... Alzheimer's disease pathology.
@nl
prefLabel
Comparison of the binding char ...... Alzheimer's disease pathology.
@en
Comparison of the binding char ...... Alzheimer's disease pathology.
@nl
P2093
P2860
P1476
Comparison of the binding char ...... Alzheimer's disease pathology.
@en
P2093
Hiroyuki Arai
Kazuhiko Yanai
Makoto Higuchi
Masahiro Maruyama
Ryuichi Harada
Shozo Furumoto
Takeo Yoshikawa
Tetsuro Tago
Yukitsuka Kudo
P2860
P2888
P304
P356
10.1007/S00259-012-2261-2
P577
2012-10-26T00:00:00Z